Ikarian Capital, LLC - ALTAMIRA THERAPEUTICS LTD ownership

ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L100. A total of 16 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of ALTAMIRA THERAPEUTICS LTD
ValueSharesWeighting
Q2 2022$36,000
-89.7%
75,000
-76.6%
0.01%
-84.8%
Q1 2022$351,000
-36.5%
320,010
+5.0%
0.05%
-43.9%
Q4 2021$553,000
-31.1%
304,791
-23.6%
0.08%
+43.9%
Q3 2021$803,000399,1480.06%
Other shareholders
ALTAMIRA THERAPEUTICS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Ikarian Capital, LLC 75,000$36,0000.01%
Virtu Financial LLC 12,907$6,0000.00%
Cutler Group LLC / CA 3,100$1,0000.00%
Stonebridge Capital Advisors LLC 100$00.00%
UBS Group AG 26,074$13,0000.00%
OSAIC HOLDINGS, INC. 310$00.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
WELLS FARGO & COMPANY/MN 500$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 80,605$39,0000.00%
View complete list of ALTAMIRA THERAPEUTICS LTD shareholders